Open Access
Issue |
Med Sci (Paris)
Volume 40, Number 5, Mai 2024
|
|
---|---|---|
Page(s) | 405 - 408 | |
Section | Nouvelles | |
DOI | https://doi.org/10.1051/medsci/2024052 | |
Published online | 31 May 2024 |
- Müller F, Escobar L, Xu F, et al. A prebiotically plausible scenario of an RNA-peptide world. Nature 2022; 605 : 279–84. [CrossRef] [PubMed] [Google Scholar]
- Fine JL, Pearlman RE. On the origin of life: an RNA-focused synthesis and narrative. RNA 2023; 29 : 1085–98. [CrossRef] [PubMed] [Google Scholar]
- McNeil BA, Semper C, Zimmerly S. Group II introns: versatile ribozymes and retroelements. WIREs RNA 2016 ; 7 : 341–355. [CrossRef] [PubMed] [Google Scholar]
- Liu ZX, Zhang S, Zhu HZ, et al. Hydrolytic endonucleolytic ribozyme (HYER) is programmable for sequence-specific DNA cleavage. Science 2024 ; 383 : eadh4859. [CrossRef] [PubMed] [Google Scholar]
- Waldern J, Schiraldi NJ, Belfort M, Novikova O. Bacterial group II introns genomic neighborhoods reflect survival strategies: hiding and hijacking. Mol Biol Evol 2020 ; 37 : 1942–8. [CrossRef] [PubMed] [Google Scholar]
- Schmidt TZN, Berarducci B, Konstantinidou S, Raffa V. CRISPR/Cas9 in the era of nanomedicine and synthetic biology. Drug discovery today 2023; 28 : 103375. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.